Consensus LENZ Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
16.35 ^USD	-1.09%		+3.94%	0.00%

15/04	Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target	MT
15/04	William Blair Starts LENZ Therapeutics With Outperform Rating	MT

1c6f10fd238d0.LMPdYF9YuGqA0NfHfXXJZZ1vLPgz-BO1TZigkCPhxAI.ZZPpBQcw8A3hgI-gGhihFKU4Z9UCtkTWF-CT8muu93FckuonOxL7KeOgsA~64949bb868282b34584861c69ba4e0eb

Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target	15/04	MT
William Blair Starts LENZ Therapeutics With Outperform Rating	15/04	MT
Piper Sandler Initiates LENZ Therapeutics at Overweight With $28 Price Target	27/03	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.35 USD

Average target price

36.75 USD

Spread / Average Target

+124.77%

High Price Target

45 USD

Spread / Highest target

+175.23%

Low Price Target

32 USD

Spread / Lowest Target

+95.72%